Tapewire

Nasdaq · USD

OKYO

OKYO Pharma Ltd

Export transactions ↓
Tapewire entity
6916
SEC CIK
0001849296
Parsed reports
41

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202670
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 27, 2026 Filed Jul 29, 2026 20:45 UTC
Patil Rajkumar V.Chief Scientific Officer
GrantCOMMON STOCK 3,363 $1.49 $5,010.87
Disclosure

SEC source: 0001493152-26-035212 · ownership.xml · nonDerivative · entry 1

Patil Rajkumar V. · CIK 0002124067 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,030

Read SEC document
July 27, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
Patil Rajkumar V.Chief Scientific Officer
PurchaseCOMMON STOCK 3,363 $1.49 $5,010.87
Disclosure

SEC source: 0001493152-26-036581 · ownership.xml · nonDerivative · entry 1

Patil Rajkumar V. · CIK 0002124067 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,030

Read SEC document
July 22, 2026 Filed Jul 23, 2026 20:20 UTC
Dempsey Robert JohnDirector · CHIEF EXECUTIVE OFFICER
GrantCOMMON STOCK 15,000 $1.54 $23,085.00
Disclosure

SEC source: 0001493152-26-034409 · ownership.xml · nonDerivative · entry 1

Dempsey Robert John · CIK 0002125298 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
July 22, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
Dempsey Robert JohnDirector · CHIEF EXECUTIVE OFFICER
PurchaseCOMMON STOCK 15,000 $1.54 $23,085.00
Disclosure

SEC source: 0001493152-26-036584 · ownership.xml · nonDerivative · entry 1

Dempsey Robert John · CIK 0002125298 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
July 21, 2026 Filed Jul 22, 2026 20:15 UTC
Mantelli FlavioCHIEF MEDICAL OFFICER
GrantCOMMON STOCK 20,000 $1.40 $28,000.00
Disclosure

SEC source: 0001493152-26-034236 · ownership.xml · nonDerivative · entry 1

Mantelli Flavio · CIK 0002127572 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:15 UTC
CERRONE GABRIELE MDirector · 10% owner
GrantCOMMON STOCK 22,500 $1.45 $32,625.00
Disclosure

SEC source: 0001493152-26-034408 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 10,873,916

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:15 UTC
JACOB GARY SDirector · CHIEF DEVELOPMENT OFFICER
GrantCOMMON STOCK 3,500 $1.40 $4,900.00
Disclosure

SEC source: 0001493152-26-034406 · ownership.xml · nonDerivative · entry 1

JACOB GARY S · CIK 0001266802 · Director · CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,420

Read SEC document
July 21, 2026 Filed Jul 23, 2026 20:15 UTC GrantCOMMON STOCK 5,000 $1.48 $7,385.00
Disclosure

SEC source: 0001493152-26-034405 · ownership.xml · nonDerivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,201

Read SEC document
July 21, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
CERRONE GABRIELE MDirector · 10% owner
PurchaseCOMMON STOCK 22,500 $1.45 $32,625.00
Disclosure

SEC source: 0001493152-26-036579 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 10,873,916

Read SEC document
July 21, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
JACOB GARY SDirector · CHIEF DEVELOPMENT OFFICER
PurchaseCOMMON STOCK 3,500 $1.40 $4,900.00
Disclosure

SEC source: 0001493152-26-036583 · ownership.xml · nonDerivative · entry 1

JACOB GARY S · CIK 0001266802 · Director · CHIEF DEVELOPMENT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,420

Read SEC document
July 21, 2026 Filed Aug 7, 2026 20:15 UTC Amendment PurchaseCOMMON STOCK 5,000 $1.48 $7,385.00
Disclosure

SEC source: 0001493152-26-036585 · ownership.xml · nonDerivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,201

Read SEC document
July 21, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
Mantelli FlavioCHIEF MEDICAL OFFICER
PurchaseCOMMON STOCK 20,000 $1.40 $28,000.00
Disclosure

SEC source: 0001493152-26-036580 · ownership.xml · nonDerivative · entry 1

Mantelli Flavio · CIK 0002127572 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
July 20, 2026 Filed Jul 21, 2026 20:15 UTC
CERRONE GABRIELE MDirector · 10% owner
GrantCOMMON STOCK 25,000 $1.40 $35,000.00
Disclosure

SEC source: 0001493152-26-034084 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 10,851,416

Read SEC document
July 20, 2026 Filed Aug 7, 2026 20:15 UTC Amendment
CERRONE GABRIELE MDirector · 10% owner
PurchaseCOMMON STOCK 25,000 $1.40 $35,000.00
Disclosure

SEC source: 0001493152-26-036582 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 10,851,416

Read SEC document
June 08, 2026 Filed Jun 10, 2026 20:30 UTC
CERRONE GABRIELE MDirector · 10% owner
GrantCOMMON STOCK 300,000 $1.72 $516,000.00
Disclosure

SEC source: 0001493152-26-028117 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 10,826,416

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:00 UTC GrantOption · Derivative 6,500 $1.85 Strike: $1.85 $12,025.00
Disclosure

SEC source: 0001493152-26-028132 · ownership.xml · derivative · entry 1

Simon Willy Jules · CIK 0001325410 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,502

Underlying: Common Shares · 6,500 shares

Expires 2036-06-08

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:00 UTC GrantOption · Derivative 6,500 $1.85 Strike: $1.85 $12,025.00
Disclosure

SEC source: 0001493152-26-028133 · ownership.xml · derivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,394

Underlying: Common Shares · 6,500 shares

Expires 2036-06-08

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:00 UTC GrantOption · Derivative 3,500 $1.85 Strike: $1.85 $6,475.00
Disclosure

SEC source: 0001493152-26-028134 · ownership.xml · derivative · entry 1

Denoyer Bernard · CIK 0001397636 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,190

Underlying: Common Shares · 3,500 shares

Expires 2036-06-08

Read SEC document
June 08, 2026 Filed Jun 10, 2026 21:00 UTC
Shah Keeren RameshchandraChief Financial Officer
GrantOption · Derivative 40,000 $1.85 Strike: $1.85 $74,000.00
Disclosure

SEC source: 0001493152-26-028131 · ownership.xml · derivative · entry 1

Shah Keeren Rameshchandra · CIK 0002125071 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544,819

Underlying: Common Shares · 40,000 shares

Expires 2036-06-08

Read SEC document
October 27, 2023 Filed Oct 31, 2023 20:15 UTC
CERRONE GABRIELE MDirector · Executive Chairman
OtherOrdinary Shares 70,071 $1.50 $105,106.50
Disclosure

SEC source: 0001493152-23-038854 · ownership.xml · nonDerivative · entry 2

CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 9,177,903

F2 · kind: Represents ordinary shares issued in lieu of cash payment to the Reporting Person.

Read SEC document
October 23, 2023 Filed Oct 31, 2023 20:15 UTC
CERRONE GABRIELE MDirector · Executive Chairman
OtherOrdinary Shares 499,468 $1.50 $749,202.00
Disclosure

SEC source: 0001493152-23-038854 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 9,107,832

F1 · kind: Represents ordinary shares received in satisfaction of bonus

Read SEC document
September 15, 2023 Filed Sep 28, 2023 10:15 UTC PurchaseOrdinary Shares 16,670 $1.50 $25,005.00
Disclosure

SEC source: 0001493152-23-034486 · ownership.xml · nonDerivative · entry 1

BRANCACCIO JOHN P · CIK 0001276551 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,670

Read SEC document
May 19, 2022 Filed May 19, 2022 15:14 UTC
CERRONE GABRIELE MDirector · Non-Executive Chairman · 10% owner
PurchaseAmerican Depositary Shares 37,500 $4.00 $150,000.00
Disclosure

SEC source: 0001493152-22-014437 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 62,500

Read SEC document
May 19, 2022 Filed May 19, 2022 15:14 UTC
JACOB GARY SDirector · Chief Executive Officer
PurchaseAmerican Depositary Shares 12,500 $4.00 $50,000.00
Disclosure

SEC source: 0001493152-22-014438 · ownership.xml · nonDerivative · entry 1

JACOB GARY S · CIK 0001266802 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Read SEC document
May 19, 2022 Filed May 20, 2022 14:35 UTC
CERRONE GABRIELE MDirector · Executive Chairman
PurchaseOrdinary Shares 5,800,000 $0.08 $440,800.00
Disclosure

SEC source: 0001493152-22-014552 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 548,981,215

Read SEC document
May 17, 2022 Filed May 18, 2022 17:38 UTC Amendment
CERRONE GABRIELE MDirector · Non-Executive Chairman · 10% owner
PurchaseAmerican Depositary Shares 25,000 $3.87 $96,750.00
Disclosure

SEC source: 0001493152-22-014299 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 25,000

Read SEC document
May 17, 2022 Filed May 18, 2022 15:37 UTC
CERRONE GABRIELE MDirector · Non-Executive Chairman · 10% owner
PurchaseOrdinary Shares 1,625,000 $0.06 $96,687.50
Disclosure

SEC source: 0001493152-22-014284 · ownership.xml · nonDerivative · entry 1

CERRONE GABRIELE M · CIK 0001139306 · Director · Non-Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Via Panetta Partners Limited

Disclosed balance after: 544,806,215

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.